Clinical Trials in Pennsylvania

Showing 15381-15400 of 19,675 trials

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

NCT01838499

The purpose of this study is to gain initial evidence for the safety, tolerability and efficacy of MEDI8968 for the treatment of subjects with moderate to severe hidradenitis suppurativa

Hidradenitis Suppurativa

AstraZeneca224 participantsStarted May 2013

Phoenix, Arizona, United States • Bakersfield, California, United States • Fremont, California, United States +24 more locations

COMPLETEDPhase 470 miles

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

NCT00329225

This 24-week study will compare the effects of adding the drug rosiglitazone (2mg and 4mg) or placebo to insulin in patients with Type 2 diabetes mellitus (non-insulin-dependent) who have not achieved their blood glucose goal using insulin alone. This study requires a total of seven visits during 28 weeks.

Diabetes Mellitus, Type 2

GlaxoSmithKline630 participantsStarted Sep 2002

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Fairfield, Alabama, United States +128 more locations

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin

Find Trials by Condition in Pennsylvania

Safety and Efficacy of Mipomersen (ISIS 301012) As Add-on Therapy in High Risk Hypercholesterolemic Patients

HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)

A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation

A Combined Tdap Vaccine Used As A Booster Compared To Licensed Td Vaccine

Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex

Neoadjuvant Sunitinib With Paclitaxel/Carboplatin in Patients With Triple-Negative Breast Cancer

Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Efficacy and Safety Study of ISIS 301012 (Mipomersen) as Add-on in Familial Hypercholesterolemic Patients With Coronary Artery Disease

Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer

Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients

Efficacy and Safety of Empagliflozin (BI 10773) With Metformin in Patients With Type 2 Diabetes

Clinical Decision Rule Validation Study to Predict Low Recurrent Risk in Patients With Unprovoked Venous Thromboembolism

Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose Monitors

Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit

Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461

A Study of MM-121 in Combination With Paclitaxel in Patients With Advanced Gynecologic and Breast Cancers

Dose-finding Study of MT-1303